Have a personal or library account? Click to login
PEG-liposomal doxorubicin as a potential agent for canine metastatic osteosarcoma – in vitro and ex ovo studies Cover

PEG-liposomal doxorubicin as a potential agent for canine metastatic osteosarcoma – in vitro and ex ovo studies

Open Access
|Jun 2023

Authors

Magdalena Walewska

magdalenawalewska13@gmail.com

Department of Small Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland

Anna Małek

Department of Small Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland

Bartosz Taciak

Department of Cancer Biology, Institute of Biology, Warsaw University of Life Sciences, Warsaw, Poland

Anna Wojtalewicz

Department of Small Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland

Sylwia Wilk

Department of Small Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland

Agata Wojtkowska

Department of Small Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland

Katarzyna Zabielska-Koczywąs

Department of Small Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland

Roman Lechowski

Department of Small Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland
Language: English
Page range: 297 - 305
Submitted on: Feb 15, 2023
Accepted on: Apr 19, 2023
Published on: Jun 16, 2023
Published by: National Veterinary Research Institute in Pulawy
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2023 Magdalena Walewska, Anna Małek, Bartosz Taciak, Anna Wojtalewicz, Sylwia Wilk, Agata Wojtkowska, Katarzyna Zabielska-Koczywąs, Roman Lechowski, published by National Veterinary Research Institute in Pulawy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.